Cargando…

Alterations of gut microbiome and effects of probiotic therapy in patients with liver cirrhosis: A systematic review and meta-analysis

Alterations in the gut microbiome usually occur in liver cirrhosis. Gut microbiome dysregulation damages the liver and accelerates the development of liver fibrosis. Probiotic treatment has gradually become a major method for improving the prognosis of liver cirrhosis and reducing its complications....

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Long, Yu, Qingsheng, Peng, Hui, Zhen, Zhou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794299/ https://www.ncbi.nlm.nih.gov/pubmed/36595801 http://dx.doi.org/10.1097/MD.0000000000032335

Ejemplares similares

The efficacy of a multistrain probiotic on cognitive function and risk of falls in patients with cirrhosis: A protocol for systematic review and meta-analysis
por: Wang, Na, et al.
Publicado: (2021)

Efficacy of probiotics on nonalcoholic fatty liver disease: A meta-analysis
por: Zhou, Xiangyu, et al.
Publicado: (2023)

Child–Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Observational Studies
por: Peng, Ying, et al.
Publicado: (2016)

Effect of portal vein thrombosis on the prognosis of patients with cirrhosis without a liver transplant: A systematic review and meta-analysis
por: Xian, Jianchun, et al.
Publicado: (2021)

Association of loss of muscle mass with mortality in liver cirrhosis without or before liver transplantation: A systematic review and meta-analysis
por: Chang, Ke-Vin, et al.
Publicado: (2019)

Meta-analysis of influences of Biejiajian Pill combined with entecavir on serum liver fibrosis markers of compensatory period of hepatitis b cirrhosis: Protocol of systematic review and meta-analysis
por: Zhang, Tianyao, et al.
Publicado: (2019)

Probiotics and rifaximin for the prevention of travelers’ diarrhea: A systematic review and network meta-analysis
por: Fan, Hao, et al.
Publicado: (2022)

Covered TIPS for secondary prophylaxis of variceal bleeding in liver cirrhosis: A systematic review and meta-analysis of randomized controlled trials
por: Qi, Xingshun, et al.
Publicado: (2016)

Predictive value of liver cirrhosis using metabolite biomarkers of bile acid in the blood: A protocol for systematic review and meta-analysis
por: Han, Xu, et al.
Publicado: (2022)

Quantitative liver surface nodularity score based on imaging for assessment of early cirrhosis in patients with chronic liver disease: A protocol for systematic review and meta-analysis
por: He, Yuhao, et al.
Publicado: (2021)

Alterations in the gut microbiota and the efficacy of adjuvant probiotic therapy in liver cirrhosis
por: Wu, Zengrong, et al.
Publicado: (2023)

Efficacy of prebiotics and probiotics for functional dyspepsia: A systematic review and meta-analysis
por: Zhang, Jiaqi, et al.
Publicado: (2020)

Liver cirrhosis caused by chronic Budd–Chiari syndrome
por: Lin, Mengjie, et al.
Publicado: (2017)

Network Meta-Analysis of Randomized Controlled Trials: Efficacy and Safety of UDCA-Based Therapies in Primary Biliary Cirrhosis
por: Zhu, Gui-Qi, et al.
Publicado: (2015)

Prognostic significance of nonprotein respiratory quotient in patients with liver cirrhosis
por: Nishikawa, Hiroki, et al.
Publicado: (2017)

Lower liver cancer risk with antiviral therapy in chronic hepatitis B patients with normal to minimally elevated ALT and no cirrhosis
por: Hoang, Joseph K., et al.
Publicado: (2016)

Gut microbiome-targeted therapies in liver cirrhosis: a protocol for systematic review and meta-analysis
por: Jiang, Honglin, et al.
Publicado: (2022)

Traditional Chinese medicine on treating splenomegaly due to portal hypertension in cirrhosis: A protocol for systematic review and meta-analysis
por: Wang, Zhaodi, et al.
Publicado: (2021)

Comparative of the effectiveness and safety of biological agents, small molecule drugs, and microbiome therapies in ulcerative colitis: Systematic review and network meta-analysis
por: Gao, Jie, et al.
Publicado: (2023)

Diagnostic Accuracy of APRI, AAR, FIB-4, FI, King, Lok, Forns, and FibroIndex Scores in Predicting the Presence of Esophageal Varices in Liver Cirrhosis: A Systematic Review and Meta-Analysis
por: Deng, Han, et al.
Publicado: (2015)

Treatment of primary biliary cirrhosis with ursodeoxycholic acid combined with traditional Chinese medicine: A protocol for systematic review and meta analysis
por: Chen, Xing, et al.
Publicado: (2020)

Correlation of platelets count with endoscopic findings in a cohort of Egyptian patients with liver cirrhosis
por: Abd-Elsalam, Sherief, et al.
Publicado: (2016)

Proton pump inhibitor use is associated with a variety of infections in patients with liver cirrhosis
por: Labenz, Christian, et al.
Publicado: (2020)

Acupoint embedding therapy improves nonalcoholic fatty liver disease with abnormal transaminase: A PRISMA-compliant systematic review and meta-analysis
por: Dai, Liang, et al.
Publicado: (2020)

Liver transplantation for decompensated liver cirrhosis caused by progressive familial intrahepatic cholestasis type 3: A case report
por: Xiang, Deng, et al.
Publicado: (2017)

A meta-analysis of the effects of probiotics and synbiotics in children with acute diarrhea
por: Yang, Bo, et al.
Publicado: (2019)

Celiac disease serology and gut microbiome following proton pump inhibitor treatment
por: Jang, Sophie, et al.
Publicado: (2020)

Liver cirrhosis: a risk factor for gallstone disease in chronic hepatitis C patients in China
por: Li, Xu, et al.
Publicado: (2017)

Endoscopic ultrasonography predicts early esophageal variceal bleeding in liver cirrhosis: A case report
por: Men, Changjun, et al.
Publicado: (2017)

How is gut microbiome of patients with familial adenomatous polyposis different from healthy people?
por: Kim, Jae Hyun, et al.
Publicado: (2022)

Red cell distribution width-to-lymphocyte ratio: A novel predictor for HBV-related liver cirrhosis
por: Zhang, Xueyan, et al.
Publicado: (2020)

Skeletal muscle volume loss among liver cirrhosis patients receiving levocarnitine predicts poor prognosis
por: Fujita, Masashi, et al.
Publicado: (2020)

Chronic hepatitis C virus infection: Relationships between inflammatory marker levels and compensated liver cirrhosis
por: Li, Xu, et al.
Publicado: (2019)

A case report of glecaprevir/pibrentasvir-induced severe hyperbilirubinemia in a patient with compensated liver cirrhosis
por: Yoon, Jae Hyun, et al.
Publicado: (2019)

Statins on nonalcoholic fatty liver disease: A systematic review and meta-analysis of 14 RCTs
por: Zhou, Haiyan, et al.
Publicado: (2023)

Resting-state functional brain alterations in functional dyspepsia: Protocol for a systematic review and voxel-based meta-analysis
por: Sun, Ruirui, et al.
Publicado: (2020)

CLIF–SOFA score and SIRS are independent prognostic factors in patients with hepatic encephalopathy due to alcoholic liver cirrhosis
por: Jeong, Jin Hee, et al.
Publicado: (2016)

The role of IL22 polymorphisms on liver cirrhosis in patients with hepatitis B virus: A case control study
por: Gao, Yan-Hang, et al.
Publicado: (2019)

Comparison of survival outcomes of alcohol-related hepatocellular carcinoma with or without liver cirrhosis; a ten-year experience
por: Shin, Jongbeom, et al.
Publicado: (2019)

Probiotics, prebiotics, antibiotic, Chinese herbal medicine, and fecal microbiota transplantation in irritable bowel syndrome: Protocol for a systematic review and network meta-analysis
por: He, Ying, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fpv0pimq0kjqela0o9cpe0dior